BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 26242155)

  • 1. [METHODOLOGIC PROBLEMS OF SENTINEL LYMPH NODE BIOPSY IN PATIENTS WITH BREAST CANCER].
    Krivorotko PV; Kanaev SV; Semiglazov VF; Novikov SN; Krzhivitsky PI; Semenov II; Turkevich EA; Busko EA; Donskikh RV; Bryantseva ZhV; Piskunov EA; Trufanova ES; Chernaya AV
    Vopr Onkol; 2015; 61(3):418-23. PubMed ID: 26242155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Methodological issues of sentinel lymph nodes biopsy in patients with breast cancer].
    Kanaev SV; Novikov SN; Krivorot'ko PV; Semiglazov VF; Zhukova LA; Krzhivitskiĭ PI
    Vopr Onkol; 2013; 59(2):90-4. PubMed ID: 23814856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer patients with extra-axillary sentinel nodes only may be spared axillary lymph node dissection.
    van der Ploeg IM; Tanis PJ; Valdés Olmos RA; Kroon BB; Rutgers EJ; Nieweg OE
    Ann Surg Oncol; 2008 Nov; 15(11):3239-43. PubMed ID: 18773244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of intraoperative frozen section examination of sentinel lymph nodes in breast cancer.
    van de Vrande S; Meijer J; Rijnders A; Klinkenbijl JH
    Eur J Surg Oncol; 2009 Mar; 35(3):276-80. PubMed ID: 18786801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gamma-probe-guided resection of the sentinel lymph node in breast cancer.
    Crossin JA; Johnson AC; Stewart PB; Turner WW
    Am Surg; 1998 Jul; 64(7):666-8; discussion 669. PubMed ID: 9655279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeat sentinel lymph node biopsy in patients with ipsilateral recurrent breast cancer after breast-conserving therapy and negative sentinel lymph node biopsy: a prospective study.
    Folli S; Falco G; Mingozzi M; Buggi F; Curcio A; Ferrari G; Taffurelli M; Regolo L; Nanni O
    Minerva Chir; 2016 Apr; 71(2):73-9. PubMed ID: 26207566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable, or nonpalpable breast cancer.
    Kumar R; Jana S; Heiba SI; Dakhel M; Axelrod D; Siegel B; Bernik S; Mills C; Wallack M; Abdel-Dayem HM
    J Nucl Med; 2003 Jan; 44(1):7-10. PubMed ID: 12515869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel lymph node biopsy in breast cancer: review on various methodological approaches.
    Zengel B; Yararbas U; Sirinocak A; Ozkok G; Denecli AG; Postaci H; Uslu A
    Tumori; 2013; 99(2):149-53. PubMed ID: 23748806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimized sentinel node scintigraphy in breast cancer.
    Paganelli G; De Cicco C; Cremonesi M; Prisco G; Calza P; Luini A; Zucali P; Veronesi U
    Q J Nucl Med; 1998 Mar; 42(1):49-53. PubMed ID: 9646645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioguided sentinel lymph node biopsy in breast cancer surgery.
    Mariani G; Moresco L; Viale G; Villa G; Bagnasco M; Canavese G; Buscombe J; Strauss HW; Paganelli G
    J Nucl Med; 2001 Aug; 42(8):1198-215. PubMed ID: 11483681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pilot study comparing the accuracy of lymphoscintigraphy sentinel lymph node localisation with axillary node dissection in women with operable breast cancer.
    Allen B; Campbell I; Desai S; Dray M; Scarlet J
    N Z Med J; 2001 May; 114(1132):233-6. PubMed ID: 11453361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sentinel node biopsy versus low axillary sampling in women with clinically node negative operable breast cancer.
    Parmar V; Hawaldar R; Nair NS; Shet T; Vanmali V; Desai S; Gupta S; Rangrajan V; Mittra I; Badwe RA
    Breast; 2013 Dec; 22(6):1081-6. PubMed ID: 23948301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.
    Veronesi U; Paganelli G; Galimberti V; Viale G; Zurrida S; Bedoni M; Costa A; de Cicco C; Geraghty JG; Luini A; Sacchini V; Veronesi P
    Lancet; 1997 Jun; 349(9069):1864-7. PubMed ID: 9217757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphoscintigraphic visualization of internal mammary nodes with subtumoral injection of radiocolloid in patients with breast cancer.
    Shimazu K; Tamaki Y; Taguchi T; Motomura K; Inaji H; Koyama H; Kasugai T; Wada A; Noguchi S
    Ann Surg; 2003 Mar; 237(3):390-8. PubMed ID: 12616124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Validation protocol of sentinel node biopsy for breast cancer using radioactive tracer at the Institute of Oncology Bucharest "Prof. Dr. Alexandru Trestioreanu"].
    Blidaru A; Bordea C; Voinea S; Condrea I; Albert P; Houcheimi B
    Chirurgia (Bucur); 2006; 101(4):391-9. PubMed ID: 17059150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of the lymphoscintigraphy in the evaluation of non-axillary sentinel lymph node localization in breast cancer.
    Gherghe M; Bordea C; Blidaru A
    Chirurgia (Bucur); 2015; 110(1):26-32. PubMed ID: 25800312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sentinel lymph node biopsy in the treatment of breast cancer. Experience in 527 cases.
    Procaccini E; Ruggiero R; Docimo G; Iovino F; Procaccini F; De Luca R; Irlandese E; Gili S; Lo Schiavo F
    Minerva Chir; 2007 Apr; 62(2):93-9. PubMed ID: 17353851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial axillary staging of breast cancer using ultrasound-guided fine needle aspiration: a liquid-based cytology study.
    Schiettecatte A; Bourgain C; Breucq C; Buls N; De Wilde V; de Mey J
    Cytopathology; 2011 Feb; 22(1):30-5. PubMed ID: 20337693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An original approach in the diagnosis of early breast cancer: use of the same radiopharmaceutical for both non-palpable lesions and sentinel node localisation.
    Feggi L; Basaglia E; Corcione S; Querzoli P; Soliani G; Ascanelli S; Prandini N; Bergossi L; Carcoforo P
    Eur J Nucl Med; 2001 Nov; 28(11):1589-96. PubMed ID: 11702098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.